Moderna sues Pfizer and BioNTech for mRNA patent infringement
CAMBRIDGE, MA, August 27, 2022—Moderna, Inc., a $53.5 billion biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, filed patent
Read moreCAMBRIDGE, MA, August 27, 2022—Moderna, Inc., a $53.5 billion biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, filed patent
Read moreShortly after the Food and Drug Administration (FDA) granted approval for the Comirnaty COVID-19 vaccine, the Lynnwood Times asked the
Read moreThe rise of vaccine mandates has many seeking religious exemptions. For members of the Church of Jesus Christ of Latter-Day
Read moreOn August 23, the Food and Drug Administration granted approval for a COVID-19 vaccine. But the jab in question is
Read more